Literature DB >> 8639704

The WT1 Wilms' tumor suppressor gene: how much do we really know?

J C Reddy1, J D Licht.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8639704     DOI： 10.1016/0304-419x(95)00014-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  36 in total

1.  Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.

Authors:  J H Laity; H J Dyson; P E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  The murine Sim-2 gene product inhibits transcription by active repression and functional interference.

Authors:  P Moffett; M Reece; J Pelletier
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.

Authors:  A K Charles; K W Brown; P J Berry
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.

Authors:  M T Discenza; M Dehbi; J Pelletier
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

5.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

6.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

7.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

8.  Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).

Authors:  Hiroya Tamaki; Machiko Mishima; Manabu Kawakami; Akihiro Tsuboi; Eui Ho Kim; Naoki Hosen; Kazuhiro Ikegame; Masaki Murakami; Tatsuya Fujioka; Tomoki Masuda; Yuki Taniguchi; Sumiyuki Nishida; Kazuoki Osumi; Toshihiro Soma; Yusuke Oji; Yoshihiro Oka; Ichiro Kawase; Haruo Sugiyama; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

9.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

Review 10.  Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays.

Authors:  Amde Selassie Shifera; John A Hardin
Journal:  Anal Biochem       Date:  2009-09-27       Impact factor: 3.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.